Lisa Linck-Paulus
Overview
Explore the profile of Lisa Linck-Paulus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meissgeier T, Kappelmann-Fenzl M, Staebler S, Ahari A, Mertes C, Gagneur J, et al.
Cell Prolif
. 2024 Aug;
58(2):e13741.
PMID: 39212334
Abnormalities in alternative splicing are a hallmark of cancer formation. In this study, we investigated the role of the splicing factor PHD finger protein 5A (PHF5A) in melanoma. Malignant melanoma...
2.
Soederberg A, Meissgeier T, Bosserhoff A, Linck-Paulus L
Cells
. 2022 Dec;
11(23).
PMID: 36497117
Cutaneous malignant melanoma is a highly proliferative and aggressive skin cancer with a steadily increasing incidence and a low long-term survival rate after metastatic progression. The protein MAGOH and its...
3.
Linck-Paulus L, Meissgeier T, Pieger K, Horn A, Matthies A, Fischer S, et al.
Cell Mol Life Sci
. 2022 Aug;
79(9):475.
PMID: 35943635
In malignant melanoma, a highly aggressive form of skin cancer, many microRNAs are aberrantly expressed contributing to tumorigenesis and progression. Further, deregulation of microRNA processing enzymes, like the miRNA-binding protein...
4.
Rachinger N, Fischer S, Bohme I, Linck-Paulus L, Kuphal S, Kappelmann-Fenzl M, et al.
Int J Mol Sci
. 2021 Sep;
22(17).
PMID: 34502254
Molecular analyses of normal and diseased cells give insight into changes in gene expression and help in understanding the background of pathophysiological processes. Years after cDNA microarrays were established in...
5.
Linck-Paulus L, Lammerhirt L, Voller D, Meyer K, Engelmann J, Spang R, et al.
J Clin Med
. 2021 Jun;
10(11).
PMID: 34073664
Malignant melanoma is one of the most dangerous tumor types due to its high metastasis rates and a steadily increasing incidence. During tumorigenesis, the molecular processes of embryonic development, exemplified...
6.
Linck-Paulus L, Hellerbrand C, Bosserhoff A, Dietrich P
Cells
. 2020 Jan;
9(1).
PMID: 31906510
In this review, we summarize the current knowledge on miRNAs as therapeutic targets in two cancer types that were frequently described to be driven by miRNAs-melanoma and hepatocellular carcinoma (HCC)....